Last Updated:
Name Designation Appointment Date Status
Shanmugam Muthusamy

Appointed as Director since October 2017

 Director 06-Oct-2017 Current
Premium access

Complete director details

Unlock the complete director and KMP records available for Sthree Pharmaceuticals Private Limited.

  • Complete appointment and designation records
  • Current and past company associations
  • Shareholding and remuneration where filed

Verified entity values are shown only after access is granted.
Ayyavu Rajavel

Appointed as Director since October 2017

 Director 06-Oct-2017 Current
Jayanthy Ayyavu Shanmugam

Appointed as Director since October 2017

 Director 06-Oct-2017 Current
Duraisamy Sengottuvelu

Appointed as Director since August 2015

 Director 13-Aug-2015 Current

People Timeline

Explore the timeline of key personnel in Sthree Pharmaceuticals Private Limited's leadership journey.

Contact Details
  • Address Sf No. 534/4A2b, Chettinadu Hospital Road, Padur, Chennai Tamil Nadu, 603103, India
  • Telephone Upgrade
  • Email Upgrade
  • Pin Code 603103
  • Country India
  • Website -
Frequently Asked Questions
You can contact Sthree Pharmaceuticals Private Limited through their registered address at Sf No. 534/4A2B, Chettinadu Hospital Road, Padur, Chennai Tamil Nadu, 603103, India, or via their website if available. Social media links are also provided where applicable.
The current directors of Sthree Pharmaceuticals Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • AYYAVU RAJAVEL
  • JAYANTHY AYYAVU SHANMUGAM
  • SHANMUGAM MUTHUSAMY
  • DURAISAMY SENGOTTUVELU
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available